US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Biocryst Pharmaceuticals

8.29

-0.5150-5.85%

Post-market: 8.390.1000+1.21%19:30 EDT

Volume:9.00M

Turnover:73.92M

Market Cap:2.12B

PE:-5.51

High:8.46

Open:8.34

Low:8.05

Close:8.81

52wk High:11.22

52wk Low:6.00

Shares:255.54M

Float Shares:222.00M

Volume Ratio:2.10

T/O Rate:4.05%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.5054

EPS(LYR):1.21

ROE:587.33%

ROA:52.86%

PB:-4.66

PE(LYR):6.85

Loading ...

Overview Company News Filings

BioCryst grants 61,750 RSUs to six new hires under inducement plan

BioCryst licenses navenibart Europe rights to Neopharmed Gentili affiliate for $70 million upfront

BioCryst Pharmaceuticals Inc - to Receive Tiered Royalties of 18%-30% on Net Sales

THOMSON REUTERS

BioCryst Pharmaceuticals Inc - to Receive $70 Mln Upfront and up to $275 Mln in Milestone Payments

THOMSON REUTERS

BioCryst Pharmaceuticals Inc - Navenibart Phase 3 Program on Track for US Regulatory Filing by End of 2027

THOMSON REUTERS

BioCryst Announces European Licensing Agreement With Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema

THOMSON REUTERS

Earning Preview: Biocryst Pharmaceuticals this quarter’s revenue is expected to increase by 19.12%, and institutional views are broadly bullish

BioCryst Pharmaceuticals announces annual shareholder meeting

Tenax Therapeutics names Thomas R. Staab CFO, replacing interim CFO Thomas McGauley

Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW) and BioCryst (BCRX)

BioCryst to report first-quarter financial results, host conference call and webcast

A Look At BioCryst Pharmaceuticals (BCRX) Valuation After New R&D Leadership Appointment

Simply Wall St.

BioCryst files Form 3 for Chief R&D Officer Sandeep Menon

BioCryst names Sandeep Menon chief research and development officer

Press Release: BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer

BioCryst grants inducement equity awards to 12 new hires under Nasdaq rule 5635(c)(4)

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

BioCryst Shares Remain Undervalued, RBC Says

MT Newswires Live

RBC Capital Sticks to Their Buy Rating for BioCryst (BCRX)

BioCryst director Theresa Heggie disposes of USD 504,000 in common shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/BCRX/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BCRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCRX\",,,,,undefined,":{"symbol":"BCRX","market":"US","secType":"STK","nameCN":"Biocryst Pharmaceuticals","latestPrice":8.29,"timestamp":1789070400000,"preClose":8.805,"halted":0,"volume":9001379,"hourTrading":{"tag":"盘后","latestPrice":8.39,"preClose":8.29,"latestTime":"19:30 EDT","volume":518059,"amount":4294744.1116,"timestamp":1789083007949,"change":0.1,"changeRate":0.012063,"amplitude":0.022907},"delay":0,"changeRate":-0.05848949460533794,"floatShares":222000000,"shares":255535105,"eps":-1.5053626,"marketStatus":"Not Yet Opened","change":-0.515,"latestTime":"09-10 16:00:00 EDT","open":8.34,"high":8.46,"low":8.045,"amount":73922834.88580999,"amplitude":0.047132,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.5053626,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789113600000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":762670800000,"exchange":"NASDAQ","adjPreClose":8.805,"preHourTrading":{"tag":"盘前","latestPrice":8.34,"preClose":8.805,"latestTime":"09:29 EDT","volume":19041,"amount":164263.08921,"timestamp":1789046999013,"change":-0.465,"changeRate":-0.052811,"amplitude":0.073822},"postHourTrading":{"tag":"盘后","latestPrice":8.39,"preClose":8.29,"latestTime":"19:30 EDT","volume":518059,"amount":4294744.1116,"timestamp":1789083007949,"change":0.1,"changeRate":0.012063,"amplitude":0.022907},"volumeRatio":2.099171,"impliedVol":0.6094,"impliedVolPercentile":0.4104},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCRX\",,,,,undefined,":{"symbol":"BCRX","floatShares":222000000,"roa":"52.86%","roe":"587.33%","lyrEps":1.21,"volumeRatio":2.099171,"shares":255535105,"dividePrice":0,"high":8.46,"amplitude":0.047132,"preClose":8.805,"low":8.045,"week52Low":6,"pbRate":"-4.66","psRate":"2.25","week52High":11.22,"institutionHeld":0.9,"latestPrice":8.29,"eps":-1.5053626,"divideRate":0,"volume":9001379,"delay":0,"ttmEps":-1.5053626,"open":8.34,"prevYearClose":7.8,"prevWeekClose":9.96,"prevMonthClose":9.7,"prevQuarterClose":10,"fiveDayClose":10.17,"twentyDayClose":10.59,"sixtyDayClose":9.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"BCRX","fiscalQuarterEnding":"2026/06","expectedEps":0.14,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"pre","actualEps":0.3},{"market":"US","date":"2026-05-06","symbol":"BCRX","fiscalQuarterEnding":"2026/03","expectedEps":0.06,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"pre","actualEps":-0.03},{"market":"US","date":"2026-02-26","symbol":"BCRX","fiscalQuarterEnding":"2025/12","expectedEps":0.07,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"pre","actualEps":1.12},{"date":"2026-01-12","symbol":"BCRX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1768208400000,"name":null,"time":"Pre-MKt","dateTimestamp":1768194000000,"actualEps":null},{"market":"US","date":"2025-11-03","symbol":"BCRX","fiscalQuarterEnding":"2025/09","expectedEps":0.07,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762146000000,"reportTimeType":"pre","actualEps":0.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.5455,"hold":0.1818,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1784001600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BCRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BCRX","date":"2026-09-09","current":-5.506979,"percent":0.732899,"low":-214.840749,"twenty":-17.279915,"median":-10.547521,"eighty":-5.405319,"high":9.400473,"avg":-22.634248,"sd":42.044776,"marketCap":2316425726},"quantilePoints":[{"date":"2021-09-17","current":-13.117184,"twenty":-11.324018,"median":-8.334355,"eighty":-5.206578,"marketCap":2808257869},{"date":"2021-09-24","current":-12.465502,"twenty":-11.369016,"median":-8.334355,"eighty":-5.206578,"marketCap":2668739325},{"date":"2021-10-01","current":-11.47127,"twenty":-11.405963,"median":-8.334355,"eighty":-5.206578,"marketCap":2455884111},{"date":"2021-10-08","current":-12.081177,"twenty":-11.447508,"median":-8.334355,"eighty":-5.206578,"marketCap":2586459158},{"date":"2021-10-15","current":-12.640955,"twenty":-11.477201,"median":-8.334355,"eighty":-5.206578,"marketCap":2706302010},{"date":"2021-10-22","current":-12.281694,"twenty":-11.564062,"median":-8.334355,"eighty":-5.206578,"marketCap":2629387941},{"date":"2021-10-29","current":-12.473857,"twenty":-11.671007,"median":-8.334355,"eighty":-5.206578,"marketCap":2670528025},{"date":"2021-11-05","current":-9.846756,"twenty":-11.693218,"median":-8.334355,"eighty":-5.206578,"marketCap":2233007882},{"date":"2021-11-12","current":-9.719803,"twenty":-11.693218,"median":-8.334355,"eighty":-5.206578,"marketCap":2204218094},{"date":"2021-11-19","current":-9.43416,"twenty":-11.671007,"median":-8.334355,"eighty":-5.206578,"marketCap":2139441073},{"date":"2021-11-26","current":-9.902297,"twenty":-11.566663,"median":-8.334355,"eighty":-5.206578,"marketCap":2245603414},{"date":"2021-12-03","current":-9.077106,"twenty":-11.566663,"median":-8.334355,"eighty":-5.206578,"marketCap":2058469796},{"date":"2021-12-10","current":-9.243731,"twenty":-11.566663,"median":-8.334355,"eighty":-5.206578,"marketCap":2096256392},{"date":"2021-12-17","current":-10.338697,"twenty":-11.547357,"median":-8.334355,"eighty":-5.206578,"marketCap":2344568308},{"date":"2021-12-23","current":-11.04487,"twenty":-11.472736,"median":-8.334355,"eighty":-5.206578,"marketCap":2504711500},{"date":"2021-12-31","current":-10.989329,"twenty":-11.41685,"median":-8.334355,"eighty":-5.206578,"marketCap":2492115968},{"date":"2022-01-07","current":-9.17232,"twenty":-11.336787,"median":-8.340324,"eighty":-5.208094,"marketCap":2080062136},{"date":"2022-01-14","current":-12.282657,"twenty":-11.336787,"median":-8.340324,"eighty":-5.208094,"marketCap":2785411927},{"date":"2022-01-21","current":-10.933787,"twenty":-11.304581,"median":-8.340324,"eighty":-5.208094,"marketCap":2479520436},{"date":"2022-01-28","current":-11.798651,"twenty":-11.300042,"median":-8.340324,"eighty":-5.208094,"marketCap":2675650862},{"date":"2022-02-04","current":-12.068425,"twenty":-11.300042,"median":-8.340324,"eighty":-5.208094,"marketCap":2736829160},{"date":"2022-02-11","current":-14.115535,"twenty":-11.300042,"median":-8.340324,"eighty":-5.208094,"marketCap":3201064482},{"date":"2022-02-18","current":-14.869315,"twenty":-11.300042,"median":-8.340324,"eighty":-5.208094,"marketCap":3372003844},{"date":"2022-02-25","current":-17.086694,"twenty":-11.307904,"median":-8.340324,"eighty":-5.208094,"marketCap":3145011000},{"date":"2022-03-04","current":-16.152465,"twenty":-11.317818,"median":-8.340324,"eighty":-5.208094,"marketCap":2973054963},{"date":"2022-03-11","current":-16.17253,"twenty":-11.317818,"median":-8.340324,"eighty":-5.208094,"marketCap":2976748199},{"date":"2022-03-18","current":-16.272856,"twenty":-11.317818,"median":-8.340324,"eighty":-5.208094,"marketCap":2995214379},{"date":"2022-03-25","current":-16.042106,"twenty":-11.317818,"median":-8.340324,"eighty":-5.208094,"marketCap":2952742166},{"date":"2022-04-01","current":-16.644061,"twenty":-11.317818,"median":-8.340324,"eighty":-5.208094,"marketCap":3063539245},{"date":"2022-04-08","current":-11.156237,"twenty":-11.307904,"median":-8.340324,"eighty":-5.208094,"marketCap":2053439204},{"date":"2022-04-14","current":-11.4221,"twenty":-11.290289,"median":-8.340324,"eighty":-5.208094,"marketCap":2102374581},{"date":"2022-04-22","current":-9.701511,"twenty":-11.173318,"median":-8.340324,"eighty":-5.208094,"marketCap":1785679596},{"date":"2022-04-29","current":-9.366496,"twenty":-11.102733,"median":-8.340324,"eighty":-5.208094,"marketCap":1724015904},{"date":"2022-05-06","current":-8.696528,"twenty":-11.021077,"median":-8.340324,"eighty":-5.208094,"marketCap":1686900384},{"date":"2022-05-13","current":-8.027101,"twenty":-11.021077,"median":-8.301129,"eighty":-5.208094,"marketCap":1557048887},{"date":"2022-05-20","current":-8.706391,"twenty":-11.021077,"median":-8.282296,"eighty":-5.208094,"marketCap":1688813453},{"date":"2022-05-27","current":-9.337843,"twenty":-11.021077,"median":-8.294118,"eighty":-5.208094,"marketCap":1811298824},{"date":"2022-06-03","current":-9.997998,"twenty":-11.021077,"median":-8.301129,"eighty":-5.208094,"marketCap":1939351713},{"date":"2022-06-10","current":-9.433518,"twenty":-11.021077,"median":-8.301129,"eighty":-5.208094,"marketCap":1829857214},{"date":"2022-06-17","current":-9.203899,"twenty":-11.021077,"median":-8.301129,"eighty":-5.208094,"marketCap":1785317079},{"date":"2022-06-24","current":-10.29459,"twenty":-11.0226,"median":-8.297309,"eighty":-5.206578,"marketCap":1996882720},{"date":"2022-07-01","current":-10.371129,"twenty":-11.0226,"median":-8.297309,"eighty":-5.206578,"marketCap":2011729432},{"date":"2022-07-08","current":-11.557495,"twenty":-11.05766,"median":-8.297309,"eighty":-5.206578,"marketCap":2241853463},{"date":"2022-07-15","current":-11.146094,"twenty":-11.094816,"median":-8.297309,"eighty":-5.206578,"marketCap":2162052388},{"date":"2022-07-22","current":-10.629451,"twenty":-11.135446,"median":-8.297309,"eighty":-5.206578,"marketCap":2061837084},{"date":"2022-07-29","current":-10.543344,"twenty":-11.135446,"median":-8.334355,"eighty":-5.206578,"marketCap":2045134533},{"date":"2022-08-05","current":-12.462268,"twenty":-11.150151,"median":-8.374928,"eighty":-5.206578,"marketCap":2612527474},{"date":"2022-08-12","current":-12.985594,"twenty":-11.22776,"median":-8.407601,"eighty":-5.296059,"marketCap":2722235034},{"date":"2022-08-19","current":-12.533227,"twenty":-11.309589,"median":-8.455336,"eighty":-5.414226,"marketCap":2627403076},{"date":"2022-08-26","current":-12.648536,"twenty":-11.405675,"median":-8.531039,"eighty":-5.512419,"marketCap":2651575928},{"date":"2022-09-02","current":-12.480008,"twenty":-11.459768,"median":-8.596328,"eighty":-5.512419,"marketCap":2616246375},{"date":"2022-09-09","current":-11.930071,"twenty":-11.491893,"median":-8.652683,"eighty":-5.514453,"marketCap":2500960465},{"date":"2022-09-16","current":-11.663973,"twenty":-11.547357,"median":-8.701649,"eighty":-5.514453,"marketCap":2445176960},{"date":"2022-09-23","current":-10.963248,"twenty":-11.566478,"median":-8.729414,"eighty":-5.514453,"marketCap":2298280397},{"date":"2022-09-30","current":-11.176126,"twenty":-11.566478,"median":-8.857482,"eighty":-5.514453,"marketCap":2342907201},{"date":"2022-10-07","current":-12.11634,"twenty":-11.645286,"median":-8.89774,"eighty":-5.514453,"marketCap":2540008918},{"date":"2022-10-14","current":-12.001031,"twenty":-11.717338,"median":-8.933652,"eighty":-5.514453,"marketCap":2515836066},{"date":"2022-10-21","current":-12.542097,"twenty":-11.764614,"median":-9.020394,"eighty":-5.514453,"marketCap":2629262526},{"date":"2022-10-28","current":-12.453398,"twenty":-11.858323,"median":-9.042565,"eighty":-5.514453,"marketCap":2610668024},{"date":"2022-11-04","current":-11.994127,"twenty":-11.860318,"median":-9.07511,"eighty":-5.514453,"marketCap":2319112507},{"date":"2022-11-11","current":-12.697963,"twenty":-11.880929,"median":-9.17232,"eighty":-5.514453,"marketCap":2455201906},{"date":"2022-11-18","current":-11.984486,"twenty":-11.950615,"median":-9.209248,"eighty":-5.514453,"marketCap":2317248269},{"date":"2022-11-25","current":-11.839862,"twenty":-11.968356,"median":-9.243731,"eighty":-5.514453,"marketCap":2289284693},{"date":"2022-12-02","current":-12.331583,"twenty":-11.996889,"median":-9.311375,"eighty":-5.514453,"marketCap":2384360849},{"date":"2022-12-09","current":-10.123661,"twenty":-11.996889,"median":-9.356661,"eighty":-5.514453,"marketCap":1957450267},{"date":"2022-12-16","current":-10.54789,"twenty":-11.996889,"median":-9.390672,"eighty":-5.514453,"marketCap":2039476754},{"date":"2022-12-23","current":-11.039611,"twenty":-11.996889,"median":-9.418291,"eighty":-5.514453,"marketCap":2134552910},{"date":"2022-12-30","current":-11.068536,"twenty":-11.996889,"median":-9.433518,"eighty":-5.514453,"marketCap":2140145625},{"date":"2023-01-06","current":-11.396349,"twenty":-11.996889,"median":-9.433518,"eighty":-5.514453,"marketCap":2203529729},{"date":"2023-01-13","current":-9.795847,"twenty":-11.996889,"median":-9.433518,"eighty":-5.514453,"marketCap":1894066163},{"date":"2023-01-20","current":-10.027245,"twenty":-11.996889,"median":-9.433518,"eighty":-5.514453,"marketCap":1938807884},{"date":"2023-01-27","current":-10.200793,"twenty":-11.996889,"median":-9.44347,"eighty":-5.514453,"marketCap":1972364174},{"date":"2023-02-03","current":-10.171868,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1966771459},{"date":"2023-02-10","current":-9.940471,"twenty":-11.996889,"median":-9.477022,"eighty":-5.514453,"marketCap":1922029738},{"date":"2023-02-17","current":-9.834413,"twenty":-11.996889,"median":-9.500944,"eighty":-5.514453,"marketCap":1901523117},{"date":"2023-02-24","current":-6.919603,"twenty":-11.996889,"median":-9.471788,"eighty":-5.514453,"marketCap":1709944600},{"date":"2023-03-03","current":-6.703271,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1656485494},{"date":"2023-03-10","current":-6.32197,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1562259925},{"date":"2023-03-17","current":-6.177076,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1526454209},{"date":"2023-03-24","current":-6.482116,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1601834664},{"date":"2023-03-31","current":-6.3601,"twenty":-11.995508,"median":-9.460929,"eighty":-5.517486,"marketCap":1571682482},{"date":"2023-04-06","current":-6.504994,"twenty":-11.995508,"median":-9.460929,"eighty":-5.517486,"marketCap":1607488198},{"date":"2023-04-14","current":-6.413482,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1584874062},{"date":"2023-04-21","current":-5.628002,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1390769391},{"date":"2023-04-28","current":-5.756703,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1422573360},{"date":"2023-05-05","current":-7.072432,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1600158879},{"date":"2023-05-12","current":-6.980582,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1579377595},{"date":"2023-05-19","current":-6.989451,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1581384167},{"date":"2023-05-26","current":-6.672128,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1509588948},{"date":"2023-06-02","current":-7.006152,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1585162862},{"date":"2023-06-09","current":-7.356877,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1664515473},{"date":"2023-06-16","current":-6.663777,"twenty":-11.996889,"median":-9.465898,"eighty":-5.514453,"marketCap":1507699600},{"date":"2023-06-23","current":-5.845419,"twenty":-11.998269,"median":-9.468843,"eighty":-5.511419,"marketCap":1322543509},{"date":"2023-06-30","current":-5.812016,"twenty":-11.99965,"median":-9.471788,"eighty":-5.508386,"marketCap":1314986117},{"date":"2023-07-07","current":-5.812016,"twenty":-11.99965,"median":-9.471788,"eighty":-5.508386,"marketCap":1314986117},{"date":"2023-07-14","current":-6.13769,"twenty":-11.99965,"median":-9.471788,"eighty":-5.508386,"marketCap":1388670684},{"date":"2023-07-21","current":-5.987379,"twenty":-11.99965,"median":-9.471788,"eighty":-5.508386,"marketCap":1354662422},{"date":"2023-07-28","current":-6.471714,"twenty":-11.99965,"median":-9.471788,"eighty":-5.508386,"marketCap":1464244599},{"date":"2023-08-04","current":-5.527341,"twenty":-11.99965,"median":-9.471788,"eighty":-5.487548,"marketCap":1341596280},{"date":"2023-08-11","current":-5.519614,"twenty":-11.99965,"median":-9.45596,"eighty":-5.447182,"marketCap":1339720706},{"date":"2023-08-18","current":-5.464964,"twenty":-11.99965,"median":-9.433518,"eighty":-5.42126,"marketCap":1326456145},{"date":"2023-08-25","current":-5.652335,"twenty":-11.99965,"median":-9.412435,"eighty":-5.42126,"marketCap":1371934641},{"date":"2023-09-01","current":-5.550842,"twenty":-11.99965,"median":-9.381701,"eighty":-5.418337,"marketCap":1347300455},{"date":"2023-09-08","current":-5.347858,"twenty":-11.99965,"median":-9.34688,"eighty":-5.418122,"marketCap":1298032084},{"date":"2023-09-15","current":-5.402508,"twenty":-11.99965,"median":-9.253895,"eighty":-5.403361,"marketCap":1311296646},{"date":"2023-09-22","current":-5.589878,"twenty":-11.99965,"median":-9.209248,"eighty":-5.402508,"marketCap":1356775142},{"date":"2023-09-29","current":-5.652335,"twenty":-11.99965,"median":-9.17232,"eighty":-5.402508,"marketCap":1371934641},{"date":"2023-10-06","current":-5.176102,"twenty":-11.99965,"median":-9.07511,"eighty":-5.347858,"marketCap":1256343463},{"date":"2023-10-13","current":-4.668641,"twenty":-11.99965,"median":-9.042565,"eighty":-5.279367,"marketCap":1133172535},{"date":"2023-10-20","current":-4.465657,"twenty":-11.99965,"median":-8.948564,"eighty":-5.203545,"marketCap":1083904164},{"date":"2023-10-27","current":-4.262672,"twenty":-12.001031,"median":-8.93448,"eighty":-5.139124,"marketCap":1034635793},{"date":"2023-11-03","current":-4.529272,"twenty":-12.001031,"median":-8.88682,"eighty":-5.005907,"marketCap":1070488920},{"date":"2023-11-10","current":-4.34144,"twenty":-12.001031,"median":-8.834028,"eighty":-4.882775,"marketCap":1026094993},{"date":"2023-11-17","current":-4.454092,"twenty":-12.001031,"median":-8.801384,"eighty":-4.760324,"marketCap":1052720213},{"date":"2023-11-24","current":-4.783383,"twenty":-12.001031,"median":-8.70402,"eighty":-4.675094,"marketCap":1130547777},{"date":"2023-12-01","current":-5.095343,"twenty":-12.001031,"median":-8.655618,"eighty":-4.65615,"marketCap":1204279154},{"date":"2023-12-08","current":-4.913366,"twenty":-12.001031,"median":-8.596328,"eighty":-4.662395,"marketCap":1161269184},{"date":"2023-12-15","current":-5.571948,"twenty":-12.001031,"median":-8.515042,"eighty":-4.662395,"marketCap":1316924313},{"date":"2023-12-22","current":-4.991356,"twenty":-12.001031,"median":-8.442474,"eighty":-4.662395,"marketCap":1179702028},{"date":"2023-12-29","current":-5.277319,"twenty":-12.001031,"median":-8.374928,"eighty":-4.65615,"marketCap":1247289124},{"date":"2024-01-05","current":-5.597945,"twenty":-12.001031,"median":-8.31341,"eighty":-4.649904,"marketCap":1323068594},{"date":"2024-01-12","current":-5.60661,"twenty":-12.001031,"median":-8.201319,"eighty":-4.649904,"marketCap":1325116688},{"date":"2024-01-19","current":-4.991356,"twenty":-12.001031,"median":-8.150833,"eighty":-4.643659,"marketCap":1179702028},{"date":"2024-01-26","current":-4.722724,"twenty":-12.001031,"median":-8.091771,"eighty":-4.649904,"marketCap":1116211121},{"date":"2024-02-02","current":-4.57541,"twenty":-12.001031,"median":-7.991699,"eighty":-4.636607,"marketCap":1081393526},{"date":"2024-02-09","current":-4.610072,"twenty":-12.001031,"median":-7.838887,"eighty":-4.610072,"marketCap":1089585901},{"date":"2024-02-16","current":-4.88737,"twenty":-12.001031,"median":-7.609687,"eighty":-4.610072,"marketCap":1155124903},{"date":"2024-02-23","current":-5.043349,"twenty":-12.001031,"median":-7.563845,"eighty":-4.610072,"marketCap":1191990591},{"date":"2024-03-01","current":-5.123286,"twenty":-12.001031,"median":-7.435334,"eighty":-4.610072,"marketCap":1160624100},{"date":"2024-03-08","current":-4.713787,"twenty":-12.001031,"median":-7.353397,"eighty":-4.610072,"marketCap":1067856632},{"date":"2024-03-15","current":-4.449888,"twenty":-12.001031,"median":-7.26889,"eighty":-4.603663,"marketCap":1008073152},{"date":"2024-03-22","current":-4.995886,"twenty":-12.001031,"median":-7.213664,"eighty":-4.593526,"marketCap":1131763110},{"date":"2024-03-28","current":-4.686487,"twenty":-12.001031,"median":-7.152558,"eighty":-4.584506,"marketCap":1061672134},{"date":"2024-04-05","current":-4.185989,"twenty":-12.001031,"median":-7.089132,"eighty":-4.565435,"marketCap":948289673},{"date":"2024-04-12","current":-4.640987,"twenty":-12.001031,"median":-7.047905,"eighty":-4.535634,"marketCap":1051364637},{"date":"2024-04-19","current":-4.094989,"twenty":-12.001031,"median":-6.983186,"eighty":-4.459327,"marketCap":927674680},{"date":"2024-04-26","current":-3.788907,"twenty":-12.001031,"median":-6.960486,"eighty":-4.426785,"marketCap":858335308},{"date":"2024-05-03","current":-4.080362,"twenty":-12.001031,"median":-6.912774,"eighty":-4.341139,"marketCap":924361101},{"date":"2024-05-10","current":-5.283475,"twenty":-12.001031,"median":-6.87327,"eighty":-4.341139,"marketCap":1102053649},{"date":"2024-05-17","current":-6.401514,"twenty":-12.001031,"median":-6.822696,"eighty":-4.341139,"marketCap":1335259759},{"date":"2024-05-24","current":-6.262996,"twenty":-12.001031,"median":-6.79385,"eighty":-4.398243,"marketCap":1306366967},{"date":"2024-05-31","current":-6.500455,"twenty":-12.001031,"median":-6.79385,"eighty":-4.442608,"marketCap":1355897468},{"date":"2024-06-07","current":-6.371831,"twenty":-12.001031,"median":-6.79385,"eighty":-4.464497,"marketCap":1329068446},{"date":"2024-06-14","current":-6.164054,"twenty":-12.001031,"median":-6.79982,"eighty":-4.547101,"marketCap":1285729258},{"date":"2024-06-21","current":-6.084901,"twenty":-12.001031,"median":-6.807212,"eighty":-4.575047,"marketCap":1269219091},{"date":"2024-06-28","current":-6.045324,"twenty":-12.003012,"median":-6.830789,"eighty":-4.593526,"marketCap":1260964007},{"date":"2024-07-05","current":-6.342149,"twenty":-12.003012,"median":-6.830789,"eighty":-4.610072,"marketCap":1322877134},{"date":"2024-07-12","current":-6.96548,"twenty":-12.003012,"median":-6.839984,"eighty":-4.630756,"marketCap":1452894699},{"date":"2024-07-15","current":-7.074316,"twenty":-12.003012,"median":-6.860942,"eighty":-4.636875,"marketCap":1475596179},{"date":"2024-08-02","current":-7.034739,"twenty":-12.01194,"median":-6.912774,"eighty":-4.705393,"marketCap":1467341095},{"date":"2024-08-09","current":-11.29889,"twenty":-12.01194,"median":-6.946957,"eighty":-4.741087,"marketCap":1648880909},{"date":"2024-08-16","current":-10.81688,"twenty":-12.01194,"median":-6.980841,"eighty":-4.774717,"marketCap":1578539691},{"date":"2024-08-23","current":-11.242183,"twenty":-12.01194,"median":-7.018642,"eighty":-4.826711,"marketCap":1640605472},{"date":"2024-08-30","current":-12.234557,"twenty":-12.014338,"median":-7.070457,"eighty":-4.877587,"marketCap":1785425627},{"date":"2024-09-06","current":-11.525718,"twenty":-12.035026,"median":-7.101921,"eighty":-4.88737,"marketCap":1681982659},{"date":"2024-09-13","current":-10.987001,"twenty":-12.035026,"median":-7.152558,"eighty":-4.913366,"marketCap":1603366004},{"date":"2024-09-20","current":-11.554072,"twenty":-12.035026,"median":-7.224485,"eighty":-4.977686,"marketCap":1686120378},{"date":"2024-09-27","current":-10.745996,"twenty":-12.035026,"median":-7.281714,"eighty":-4.996539,"marketCap":1568195394},{"date":"2024-10-04","current":-10.519167,"twenty":-12.035026,"median":-7.356877,"eighty":-5.042892,"marketCap":1535093645},{"date":"2024-10-11","current":-10.093864,"twenty":-12.035026,"median":-7.468832,"eighty":-5.095343,"marketCap":1473027864},{"date":"2024-10-18","current":-10.618405,"twenty":-12.035026,"median":-7.580205,"eighty":-5.147336,"marketCap":1549575660},{"date":"2024-10-25","current":-11.596602,"twenty":-12.035026,"median":-7.766312,"eighty":-5.164667,"marketCap":1692326956},{"date":"2024-10-31","current":-11.865961,"twenty":-12.035026,"median":-8.017533,"eighty":-5.202028,"marketCap":1731635284},{"date":"2024-11-08","current":-12.831088,"twenty":-12.05083,"median":-8.266748,"eighty":-5.240678,"marketCap":1588706819},{"date":"2024-11-15","current":-12.463052,"twenty":-12.117301,"median":-8.515042,"eighty":-5.262947,"marketCap":1543137653},{"date":"2024-11-22","current":-12.529967,"twenty":-12.127993,"median":-8.696528,"eighty":-5.277751,"marketCap":1551422956},{"date":"2024-11-29","current":-12.546696,"twenty":-12.162273,"median":-8.89774,"eighty":-5.307206,"marketCap":1553494282},{"date":"2024-12-06","current":-13.11548,"twenty":-12.179299,"median":-9.041252,"eighty":-5.338414,"marketCap":1623919356},{"date":"2024-12-13","current":-12.713985,"twenty":-12.207624,"median":-9.17232,"eighty":-5.363975,"marketCap":1574207539},{"date":"2024-12-20","current":-12.362678,"twenty":-12.232231,"median":-9.243731,"eighty":-5.409294,"marketCap":1530709699},{"date":"2024-12-27","current":-12.914733,"twenty":-12.259544,"median":-9.356661,"eighty":-5.41898,"marketCap":1599063448},{"date":"2025-01-03","current":-13.098751,"twenty":-12.26852,"median":-9.418291,"eighty":-5.454663,"marketCap":1621848030},{"date":"2025-01-10","current":-13.466787,"twenty":-12.292012,"median":-9.454684,"eighty":-5.48209,"marketCap":1667417196},{"date":"2025-01-17","current":-11.810623,"twenty":-12.304269,"median":-9.573636,"eighty":-5.520157,"marketCap":1462355951},{"date":"2025-01-24","current":-12.931462,"twenty":-12.325269,"median":-9.656044,"eighty":-5.52783,"marketCap":1601134773},{"date":"2025-01-31","current":-13.165667,"twenty":-12.367034,"median":-9.698399,"eighty":-5.550842,"marketCap":1630133333},{"date":"2025-02-07","current":-14.604354,"twenty":-12.442894,"median":-9.725843,"eighty":-5.566615,"marketCap":1808267344},{"date":"2025-02-14","current":-14.754915,"twenty":-12.465502,"median":-9.795847,"eighty":-5.593158,"marketCap":1826909276},{"date":"2025-02-21","current":-15.708464,"twenty":-12.479871,"median":-9.828959,"eighty":-5.626683,"marketCap":1944974841},{"date":"2025-02-28","current":-19.913045,"twenty":-12.502,"median":-9.865139,"eighty":-5.652335,"marketCap":1769891369},{"date":"2025-03-07","current":-18.47893,"twenty":-12.529967,"median":-9.901904,"eighty":-5.678879,"marketCap":1642425757},{"date":"2025-03-14","current":-17.726607,"twenty":-12.546696,"median":-9.940471,"eighty":-5.714205,"marketCap":1575558550},{"date":"2025-03-21","current":-18.079258,"twenty":-12.59352,"median":-9.969395,"eighty":-5.738213,"marketCap":1606902553},{"date":"2025-03-28","current":-18.4084,"twenty":-12.615114,"median":-10.036268,"eighty":-5.765731,"marketCap":1636156956},{"date":"2025-04-04","current":-17.232895,"twenty":-12.640439,"median":-10.100661,"eighty":-5.812016,"marketCap":1531676946},{"date":"2025-04-11","current":-15.069967,"twenty":-12.698553,"median":-10.126993,"eighty":-5.822454,"marketCap":1339433728},{"date":"2025-04-17","current":-16.974284,"twenty":-12.71197,"median":-10.145498,"eighty":-5.831428,"marketCap":1508691344},{"date":"2025-04-25","current":-19.325293,"twenty":-12.737872,"median":-10.203083,"eighty":-5.866249,"marketCap":1717651364},{"date":"2025-05-02","current":-20.501581,"twenty":-12.762442,"median":-10.249001,"eighty":-5.885575,"marketCap":1822201052},{"date":"2025-05-09","current":-38.821072,"twenty":-12.806107,"median":-10.263824,"eighty":-5.902709,"marketCap":2075762718},{"date":"2025-05-16","current":-39.955962,"twenty":-12.825479,"median":-10.297115,"eighty":-5.902709,"marketCap":2136445297},{"date":"2025-05-23","current":-40.660377,"twenty":-12.846485,"median":-10.335775,"eighty":-5.902709,"marketCap":2174110346},{"date":"2025-05-30","current":-42.57795,"twenty":-12.857594,"median":-10.355059,"eighty":-5.902709,"marketCap":2276642981},{"date":"2025-06-06","current":-42.969291,"twenty":-12.908311,"median":-10.399955,"eighty":-5.902709,"marketCap":2297568008},{"date":"2025-06-13","current":-40.699511,"twenty":-12.928886,"median":-10.422124,"eighty":-5.902709,"marketCap":2176202849},{"date":"2025-06-20","current":-38.977609,"twenty":-12.94006,"median":-10.437012,"eighty":-5.901193,"marketCap":2084132729},{"date":"2025-06-27","current":-37.803584,"twenty":-12.994531,"median":-10.509424,"eighty":-5.901193,"marketCap":2021357646},{"date":"2025-07-03","current":-34.985926,"twenty":-13.015253,"median":-10.530976,"eighty":-5.901193,"marketCap":1870697449},{"date":"2025-07-11","current":-34.751121,"twenty":-13.083416,"median":-10.547705,"eighty":-5.901193,"marketCap":1858142433},{"date":"2025-07-18","current":-34.046706,"twenty":-13.098751,"median":-10.601323,"eighty":-5.901193,"marketCap":1820477383},{"date":"2025-07-25","current":-33.459694,"twenty":-13.132835,"median":-10.623928,"eighty":-5.901193,"marketCap":1789089842},{"date":"2025-08-01","current":-31.855194,"twenty":-13.205816,"median":-10.65337,"eighty":-5.901193,"marketCap":1703297230},{"date":"2025-08-08","current":-49.080304,"twenty":-13.242261,"median":-10.686123,"eighty":-5.901193,"marketCap":1752706750},{"date":"2025-08-15","current":-49.671744,"twenty":-13.26604,"median":-10.723698,"eighty":-5.901193,"marketCap":1773827633},{"date":"2025-08-22","current":-49.260262,"twenty":-13.401187,"median":-10.745996,"eighty":-5.901193,"marketCap":1759133203},{"date":"2025-08-29","current":-49.78931,"twenty":-13.465608,"median":-10.774079,"eighty":-5.901193,"marketCap":1778026042},{"date":"2025-09-05","current":-48.613647,"twenty":-13.493154,"median":-10.802703,"eighty":-5.930008,"marketCap":1736041956},{"date":"2025-09-12","current":-47.437985,"twenty":-13.600619,"median":-10.820878,"eighty":-5.95556,"marketCap":1694057870},{"date":"2025-09-19","current":-46.79137,"twenty":-13.669547,"median":-10.866357,"eighty":-5.95556,"marketCap":1670966622},{"date":"2025-09-26","current":-44.969093,"twenty":-13.789991,"median":-10.903154,"eighty":-5.987379,"marketCap":1605891289},{"date":"2025-10-03","current":-43.088033,"twenty":-13.833065,"median":-10.939826,"eighty":-6.004458,"marketCap":1538716751},{"date":"2025-10-10","current":-42.617768,"twenty":-13.963142,"median":-10.960947,"eighty":-6.056554,"marketCap":1521923117},{"date":"2025-10-17","current":-39.502262,"twenty":-14.085315,"median":-10.984198,"eighty":-6.088859,"marketCap":1410665289},{"date":"2025-10-24","current":-42.265069,"twenty":-14.180162,"median":-11.039611,"eighty":-6.12712,"marketCap":1509327891},{"date":"2025-10-31","current":-42.741438,"twenty":-14.263285,"median":-11.089358,"eighty":-6.154198,"marketCap":1526339476},{"date":"2025-11-07","current":-168.597661,"twenty":-14.417657,"median":-11.142945,"eighty":-6.171663,"marketCap":1480118864},{"date":"2025-11-14","current":-165.479923,"twenty":-14.55044,"median":-11.160063,"eighty":-6.196567,"marketCap":1452748245},{"date":"2025-11-21","current":-168.597661,"twenty":-14.62077,"median":-11.194519,"eighty":-6.230458,"marketCap":1480118864},{"date":"2025-11-28","current":-172.19505,"twenty":-14.698437,"median":-11.235095,"eighty":-6.231029,"marketCap":1511700348},{"date":"2025-12-05","current":-187.783739,"twenty":-14.878402,"median":-11.277624,"eighty":-6.231029,"marketCap":1648553443},{"date":"2025-12-12","current":-181.788089,"twenty":-15.125737,"median":-11.305195,"eighty":-6.231029,"marketCap":1595917637},{"date":"2025-12-19","current":-174.833136,"twenty":-15.37832,"median":-11.305195,"eighty":-6.231029,"marketCap":1534860102},{"date":"2025-12-26","current":-184.666001,"twenty":-15.67732,"median":-11.316476,"eighty":-6.231029,"marketCap":1621182824},{"date":"2026-01-02","current":-187.064261,"twenty":-15.827811,"median":-11.354561,"eighty":-6.231029,"marketCap":1642237147},{"date":"2026-01-09","current":-182.747393,"twenty":-16.019775,"median":-11.403064,"eighty":-6.231029,"marketCap":1604339366},{"date":"2026-01-16","current":-171.955225,"twenty":-16.244764,"median":-11.414808,"eighty":-6.231029,"marketCap":1509594916},{"date":"2026-01-23","current":-161.882534,"twenty":-16.309157,"median":-11.414808,"eighty":-6.231029,"marketCap":1421166762},{"date":"2026-01-30","current":-188.303258,"twenty":-16.547622,"median":-11.414808,"eighty":-6.231029,"marketCap":1653114304},{"date":"2026-02-06","current":-176.163768,"twenty":-16.702785,"median":-11.414808,"eighty":-6.231029,"marketCap":1546541717},{"date":"2026-02-13","current":-191.973337,"twenty":-16.862772,"median":-11.414808,"eighty":-6.231029,"marketCap":1685333923},{"date":"2026-02-20","current":-211.17067,"twenty":-17.036898,"median":-11.414808,"eighty":-6.231029,"marketCap":1853867315},{"date":"2026-02-27","current":7.420428,"twenty":-17.232895,"median":-11.415632,"eighty":-6.230458,"marketCap":1957961469},{"date":"2026-03-06","current":8.079274,"twenty":-17.232895,"median":-11.405991,"eighty":-6.173948,"marketCap":2131805270},{"date":"2026-03-13","current":7.965213,"twenty":-17.232895,"median":-11.353525,"eighty":-6.154198,"marketCap":2101709195},{"date":"2026-03-20","current":9.324432,"twenty":-17.232895,"median":-11.313067,"eighty":-6.124478,"marketCap":2460354082},{"date":"2026-03-27","current":9.086807,"twenty":-17.232895,"median":-11.306219,"eighty":-6.084901,"marketCap":2397653927},{"date":"2026-04-02","current":8.915716,"twenty":-17.232895,"median":-11.306219,"eighty":-6.055059,"marketCap":2352509815},{"date":"2026-04-10","current":9.400473,"twenty":-17.232895,"median":-11.306219,"eighty":-5.987379,"marketCap":2480418131},{"date":"2026-04-17","current":9.048787,"twenty":-17.232895,"median":-11.306219,"eighty":-5.953976,"marketCap":2387621902},{"date":"2026-04-24","current":8.326405,"twenty":-17.232895,"median":-11.29889,"eighty":-5.887172,"marketCap":2197013431},{"date":"2026-05-01","current":8.821349,"twenty":-17.232895,"median":-11.264059,"eighty":-5.853769,"marketCap":2327609998},{"date":"2026-05-08","current":-4.939152,"twenty":-17.232895,"median":-11.264059,"eighty":-5.817863,"marketCap":2262047674},{"date":"2026-05-15","current":-5.310976,"twenty":-17.232895,"median":-11.264059,"eighty":-5.756703,"marketCap":2432336656},{"date":"2026-05-22","current":-4.645023,"twenty":-17.232895,"median":-11.203561,"eighty":-5.734766,"marketCap":2127341464},{"date":"2026-05-29","current":-5.050144,"twenty":-17.256405,"median":-11.160063,"eighty":-5.682002,"marketCap":2312880206},{"date":"2026-06-05","current":-4.700519,"twenty":-17.232895,"median":-11.142945,"eighty":-5.652335,"marketCap":2152757730},{"date":"2026-06-12","current":-4.717168,"twenty":-17.232895,"median":-11.086238,"eighty":-5.574264,"marketCap":2160382610},{"date":"2026-06-18","current":-4.9669,"twenty":-17.232895,"median":-11.039611,"eighty":-5.558649,"marketCap":2274755807},{"date":"2026-06-26","current":-5.494113,"twenty":-17.256405,"median":-10.977426,"eighty":-5.527421,"marketCap":2516210334},{"date":"2026-07-02","current":-5.355373,"twenty":-17.256405,"median":-10.960947,"eighty":-5.518953,"marketCap":2452669669},{"date":"2026-07-10","current":-5.949181,"twenty":-17.256405,"median":-10.92462,"eighty":-5.513849,"marketCap":2724623715},{"date":"2026-07-17","current":-5.052919,"twenty":-17.256405,"median":-10.849846,"eighty":-5.491406,"marketCap":2314151019},{"date":"2026-07-24","current":-5.205533,"twenty":-17.256405,"median":-10.809791,"eighty":-5.458868,"marketCap":2384045750},{"date":"2026-07-31","current":-5.127839,"twenty":-17.279915,"median":-10.769647,"eighty":-5.418122,"marketCap":2348462978},{"date":"2026-08-07","current":-6.177913,"twenty":-17.279915,"median":-10.74426,"eighty":-5.405319,"marketCap":2376476476},{"date":"2026-08-14","current":-6.516702,"twenty":-17.279915,"median":-10.703465,"eighty":-5.405319,"marketCap":2506799380},{"date":"2026-08-21","current":-6.417058,"twenty":-17.279915,"median":-10.648586,"eighty":-5.405319,"marketCap":2468469114},{"date":"2026-08-28","current":-6.55656,"twenty":-17.279915,"median":-10.618405,"eighty":-5.405319,"marketCap":2522131486},{"date":"2026-09-04","current":-6.702704,"twenty":-17.279915,"median":-10.54789,"eighty":-5.405319,"marketCap":2578349209},{"date":"2026-09-09","current":-6.021805,"twenty":-17.279915,"median":-10.547521,"eighty":-5.405319,"marketCap":2316425726}],"updateTime":1789099716143},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BCRX\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633791287","title":"BioCryst grants 61,750 RSUs to six new hires under inducement plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2633791287","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633791287?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:11","pubTimestamp":1777979483,"startTime":"0","endTime":"0","summary":"BioCryst Pharmaceuticals granted restricted stock units covering 61,750 shares to six newly hired employees, with grant date May 1, 2026.Awards vest in four equal annual installments starting on first anniversary of grant date, contingent on continued service.Grants were issued under BioCryst Inducement Equity Incentive Plan.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL8PgkRY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4547","SG9999014039.USD","BK4588","LU2210150020.SGD","NDAQ","IE00BN0W2V16.EUR","LU0314104364.USD","IE00BKPKM429.USD","SG9999014013.SGD","SG9999014021.USD","IE00B64PRP62.GBP","SG9999014005.SGD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00BN0W2W23.USD","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","BCRX","BK4139","BK4112","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632393797","title":"BioCryst licenses navenibart Europe rights to Neopharmed Gentili affiliate for $70 million upfront","url":"https://stock-news.laohu8.com/highlight/detail?id=2632393797","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632393797?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:04","pubTimestamp":1777892698,"startTime":"0","endTime":"0","summary":"BioCryst entered licensing deal granting Irish affiliate of Neopharmed Gentili exclusive rights to commercialize navenibart for hereditary angioedema in Europe.BioCryst to receive USD 70 million upfront, up to USD 275 million in regulatory and sales milestones, royalties of 18% to 30% on net sales.Agreement extends existing relationship tied to prior deal for sale of European ORLADEYO business to Neopharmed Gentili in 2025.Navenibart Phase 3 program on track to support U.S. regulatory filing by end of 2027.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL7jJGb1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2095319765.USD","BCRX","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4112","IE00BN0W2W23.USD","LU0314104364.USD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","BK4588","SG9999014005.SGD","BK4547","SG9999014021.USD","NDAQ","BK4139","LU2210149790.SGD","IE00B64PRP62.GBP","BK4585","LU2210150020.SGD","SG9999014039.USD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632937573","title":"BioCryst Pharmaceuticals Inc - to Receive Tiered Royalties of 18%-30% on Net Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2632937573","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632937573?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:00","pubTimestamp":1777892402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nTUA5FWMXW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4547","BCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632693757","title":"BioCryst Pharmaceuticals Inc - to Receive $70 Mln Upfront and up to $275 Mln in Milestone Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2632693757","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632693757?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:00","pubTimestamp":1777892402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nTUA5FWMXW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4547","BCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632577937","title":"BioCryst Pharmaceuticals Inc - Navenibart Phase 3 Program on Track for US Regulatory Filing by End of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2632577937","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632577937?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:00","pubTimestamp":1777892402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nTUA5FWMXW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4547","BK4139","BCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632375589","title":"BioCryst Announces European Licensing Agreement With Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema","url":"https://stock-news.laohu8.com/highlight/detail?id=2632375589","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632375589?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:00","pubTimestamp":1777892402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nTUA5FWMXW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4547","BCRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175920168","title":"Earning Preview: Biocryst Pharmaceuticals this quarter’s revenue is expected to increase by 19.12%, and institutional views are broadly bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1175920168","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175920168?lang=en_us&edition=fundamental","pubTime":"2026-04-30 03:00","pubTimestamp":1777489245,"startTime":"0","endTime":"0","summary":"Abstract Biocryst Pharmaceuticals will report first-quarter 2026 results on May 6, 2026 Pre-Market, with investor attention centered on revenue growth durability from the core franchise, margin...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: Biocryst Pharmaceuticals this quarter’s revenue is expected to increase by 19.12%, and institutional views are broadly bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629850277","title":"BioCryst Pharmaceuticals announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2629850277","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629850277?lang=en_us&edition=fundamental","pubTime":"2026-04-24 04:07","pubTimestamp":1776974829,"startTime":"0","endTime":"0","summary":"BioCryst Pharmaceuticals annual shareholder meeting set for June 11, 2026 in Durham, North Carolina.Shareholders will vote to elect three directors for terms ending at 2029 annual meeting.Meeting agenda includes ratification of Ernst & Young as independent auditor for fiscal 2026.Investors will also cast advisory vote on executive compensation.Another proposal seeks approval of amended and restated Stock Incentive Plan, adding 7,000,000 shares for issuance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCryst Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 23","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL6VytVK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4547","BK4139","BCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629532048","title":"Tenax Therapeutics names Thomas R. Staab CFO, replacing interim CFO Thomas McGauley","url":"https://stock-news.laohu8.com/highlight/detail?id=2629532048","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629532048?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:04","pubTimestamp":1776855861,"startTime":"0","endTime":"0","summary":"Tenax Therapeutics named Thomas R. Staab II as chief financial officer, effective May 11, 2026.Staab most recently served as CFO and secretary of LENSAR.His prior roles include CFO positions at BioCryst Pharmaceuticals, Inspire Pharmaceuticals, Triangle Pharmaceuticals.Thomas McGauley will be replaced as interim CFO, a role he has held since December 2024.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL7VgbMD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","TENX","BK4112","BK4585","LU0314104364.USD","BCRX","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4139","BK4588","IE00BN0W2W23.USD","BK4547","SG9999014021.USD","NDAQ","IE00BN0W2V16.EUR","LU2210149790.SGD","LU2095319765.USD","IE00BKPKM429.USD","SG9999014013.SGD","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627621148","title":"Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW) and BioCryst (BCRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627621148","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627621148?lang=en_us&edition=fundamental","pubTime":"2026-04-16 22:40","pubTimestamp":1776350410,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Harrow Health (HROW) and BioCryst (BCRX) with bullis...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-harrow-health-hrow-and-biocryst-bcrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-harrow-health-hrow-and-biocryst-bcrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","XLV","BK4581","BK4588","XBI","LABU","BK4547","BK4139","LU0029874061.USD","HCSG","BCRX","BK4137","LU0128526141.USD","HROW","BK4557","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627728687","title":"BioCryst to report first-quarter financial results, host conference call and webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2627728687","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627728687?lang=en_us&edition=fundamental","pubTime":"2026-04-15 19:00","pubTimestamp":1776250827,"startTime":"0","endTime":"0","summary":"BioCryst schedules release of first-quarter 2026 financial results for May 6, 2026.Management plans conference call and webcast for May 6, 2026 at 8:30 a.m. ET.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL1Qct93:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BCRX","SG9999014021.USD","LU2210149790.SGD","NDAQ","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014039.USD","BK4112","IE00B64PRP62.GBP","LU2095319765.USD","IE00BN0W2W23.USD","BK4585","IE00BN0W2T93.GBP","BK4547","BK4588","BK4139","LU0314104364.USD","SG9999014013.SGD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626925512","title":"A Look At BioCryst Pharmaceuticals (BCRX) Valuation After New R&D Leadership Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2626925512","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626925512?lang=en_us&edition=fundamental","pubTime":"2026-04-09 00:18","pubTimestamp":1775665137,"startTime":"0","endTime":"0","summary":"BioCryst Pharmaceuticals (BCRX) is in focus after appointing Sandeep M. Menon as Chief Research and Development Officer, a leadership change that directly ties to its rare disease pipeline and longer term R&D priorities.\nSee our latest analysis for BioCryst Pharmaceuticals.\nAt a share price of $9.59, BioCryst has seen a 30 day share price return of 13.09% and year to date share price return of 27.87%, while the 1 year total shareholder return of 48.22% points to building momentum around...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bcrx/biocryst-pharmaceuticals/news/a-look-at-biocryst-pharmaceuticals-bcrx-valuation-after-new-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bcrx/biocryst-pharmaceuticals/news/a-look-at-biocryst-pharmaceuticals-bcrx-valuation-after-new-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BCRX","BK4547"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625668909","title":"BioCryst files Form 3 for Chief R&D Officer Sandeep Menon","url":"https://stock-news.laohu8.com/highlight/detail?id=2625668909","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625668909?lang=en_us&edition=fundamental","pubTime":"2026-04-08 04:23","pubTimestamp":1775593390,"startTime":"0","endTime":"0","summary":"BioCryst Pharmaceuticals Chief R&D Officer Sandeep Menon filed an initial Form 3 on April 7, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCryst Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 07, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDLFCdyf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCRX","BK4547"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625675010","title":"BioCryst names Sandeep Menon chief research and development officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2625675010","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625675010?lang=en_us&edition=fundamental","pubTime":"2026-04-06 19:01","pubTimestamp":1775473274,"startTime":"0","endTime":"0","summary":"Menon joins from Alnylam Pharmaceuticals, where he served as chief development officer overseeing global clinical development and safety.At Alnylam, he led work that supported FDA approval of AMVUTTRA  for ATTR cardiomyopathy.Menon previously held senior R&D leadership roles at Pfizer, including senior vice president and head of early clinical development.BioCryst cited ORLADEYO commercial momentum, Astria Therapeutics acquisition, and navenibart program as it moves toward a potential BLA.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260406:nNDLbW9cBL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505439.SGD","LU1883839398.USD","BK4533","IE00BKPKM429.USD","LU1066051498.USD","IE00BLSP4239.USD","LU2095319765.USD","BCRX","SG9999001176.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","LU0058720904.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0868494617.USD","BK4112","BK4568","IE00BBT3K403.USD","IE00BLSP4452.SGD","IE00BN0W2W23.USD","LU0109394709.USD","LU0122379950.USD","LU0289739699.SGD","LU0306806265.USD","LU0314104364.USD","SG9999003800.SGD","SG9999011175.SGD","LU0306807586.USD","LU1057294990.SGD","LU0114720955.EUR","LU1894683264.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","LU0170899867.USD","LU0225284248.USD","LU0456855351.SGD","LU0985481810.HKD","BK4007","BK4548","BK4550","IE00B19Z3581.USD","LU1023059063.AUD","SG9999002224.SGD","BK4588","LU1066053197.SGD","BK4547","SG9999014005.SGD","BK4534","LU0225771236.USD","SG9999001176.USD","SG9999014021.USD","SGXZ57979304.SGD","BK4139","BK4592","LU2210149790.SGD","SG9999002232.USD","IE00B64PRP62.GBP","LU0321505868.SGD","BK4599","IE000M9KFDE8.USD","BK4585","LU2210150020.SGD","LU1894683348.USD","LU0889565916.HKD","BK4581","LU0234572021.USD","SG9999014039.USD","LU0882574055.USD","IE00BGHQF748.EUR","LU0320765992.SGD","SG9999013999.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625675005","title":"Press Release: BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2625675005","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625675005?lang=en_us&edition=fundamental","pubTime":"2026-04-06 19:00","pubTimestamp":1775473200,"startTime":"0","endTime":"0","summary":"-- Experienced R&D leader with a track record of advancing innovative therapies from early development to global approval --. Dr. Menon joins BioCryst from Alnylam Pharmaceuticals, where he served as Chief Development Officer, overseeing global clinical development and safety across a broad portfolio spanning multiple therapeutic areas. Under his leadership, his team read out and secured FDA approval of AMVUTTRA , a novel RNAi therapeutic for ATTR cardiomyopathy, and advanced multiple programs through key clinical milestones.\"BioCryst is at a critical inflection point in its history and I am excited to join as the company enters its next stage of growth,\" said Dr. Sandeep Menon, Chief Research and Development Officer of BioCryst. \"BioCryst has built a growing rare disease business with strong commercial momentum, a differentiated portfolio, and a clear path to expand it. I look forward to working alongside the team to advance our development programs and deliver medicines that can tran","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4547","BK4604","ICON","BK4099","R","BK4022","BK4139","BCRX","BK4232","BK4021","BK4585","BK4555","BK4588","TM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624654456","title":"BioCryst grants inducement equity awards to 12 new hires under Nasdaq rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624654456","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624654456?lang=en_us&edition=fundamental","pubTime":"2026-04-03 19:00","pubTimestamp":1775214016,"startTime":"0","endTime":"0","summary":"BioCryst compensation committee granted inducement equity awards to 12 newly hired employees effective April 1, 2026.Awards included stock options covering 33,950 shares at an exercise price of $9.38 per share.Grants also included restricted stock units covering 123,350 shares.Options and RSUs vest in four equal annual installments starting one year from grant date.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nNDL1tCVmc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","IE00BGHQF748.EUR","LU2210149790.SGD","BK4139","BCRX","BK4585","LU0314104364.USD","IE00BKPKM429.USD","SG9999014039.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","NDAQ","SG9999014005.SGD","LU2095319765.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","BK4588","BK4112","SG9999014021.USD","BK4547","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624654481","title":"BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624654481","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624654481?lang=en_us&edition=fundamental","pubTime":"2026-04-03 19:00","pubTimestamp":1775214002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nTUA76WZTP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCRX","BK4547","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622107082","title":"BioCryst Shares Remain Undervalued, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2622107082","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622107082?lang=en_us&edition=fundamental","pubTime":"2026-03-25 23:18","pubTimestamp":1774451926,"startTime":"0","endTime":"0","summary":"BioCryst Pharmaceuticals  remains undervalued even with  a recent price increase due to unconfirmed reports of being a takeover target, RBC Capital Markets said in a Wednesday note.Even with the shares up 24% year-to-date, RBC's analysis of BioCryst in various takeout scenarios and as an independent company all projected share prices that are higher than what they are currently. The scenarios made various assumptions about the peak revenue for the company's hereditary angioedema treatments Orladeyo and Navenibart, as well as the potential discounted cash flow takeout value.RBC analysts said their analysis forecast the company's share price at $18 per share in the base case, $20 per share in the bull case, and $12 per share in the bear case.Even with the potential impact of rival Pharvaris'  Q3 data for its competing hereditary angioedema drug, Orladeyo is still likely to have a \"meaningful\" role in disease treatment, while Navenibart could see a growing role among the longer-acting pro","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BCRX","BK4547","PHVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622020425","title":"RBC Capital Sticks to Their Buy Rating for BioCryst (BCRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622020425","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622020425?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:17","pubTimestamp":1774437431,"startTime":"0","endTime":"0","summary":"In a report released today, Brian Abrahams from RBC Capital maintained a Buy rating on BioCryst, with a price target of $13.00. Abrahams covers the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-buy-rating-for-biocryst-bcrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-buy-rating-for-biocryst-bcrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622018237","title":"BioCryst director Theresa Heggie disposes of USD 504,000 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2622018237","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622018237?lang=en_us&edition=fundamental","pubTime":"2026-03-25 04:04","pubTimestamp":1774382663,"startTime":"0","endTime":"0","summary":"BioCryst reported a change in beneficial ownership by director Theresa Heggie.Theresa Heggie exercised an option to acquire 49,933 common shares at USD 6.3 per share on March 20, 2026.She also sold 49,933 common shares at a weighted average price of USD 10.11 per share on March 20, 2026.Following the transactions, she beneficially owned 65,352 common shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCryst Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 24, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDLGxbkg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BioCryst director Theresa Heggie disposes of USD 504,000 in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCRX","BK4139","BK4547"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":102,"code":"91000000","status":"200"}]}}